PENG FAN

NORTH HOLLYWOOD, CA NPI 1104801463

General Payments — all program years on this page

$387,705.28

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 710
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $7,277.12 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GENZYME CORPORATION $6,378.1210
Amgen Inc. $800.002
SANOFI-AVENTIS U.S. LLC $99.001

By program year

Program yearAmountRecords
2018 $156,124.04335
2019 $184,395.77272
2020 $21,271.6336
2021 $5,396.5817
2022 $3,948.9513
2023 $9,291.1924
2024 $7,277.1213

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1115613462 Amgen Inc. $200.00 02/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1115613473 Amgen Inc. $600.00 02/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1139843849 GENZYME CORPORATION $478.64 01/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139843851 GENZYME CORPORATION $173.34 01/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139843853 GENZYME CORPORATION $189.14 01/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139843855 GENZYME CORPORATION $72.12 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139843857 GENZYME CORPORATION $35.39 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139843859 GENZYME CORPORATION $50.13 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139843861 GENZYME CORPORATION $80.03 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139843863 GENZYME CORPORATION $37.10 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139843865 GENZYME CORPORATION $174.23 01/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139843871 GENZYME CORPORATION $5,088.00 01/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1139843885 SANOFI-AVENTIS U.S. LLC $99.00 10/18/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.